Name: Latest research reports of Ipca Laboratories Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Sharekhan

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet

1362.2000 0.40 (0.03%)

NSE Jun 19, 2025 15:31 PM

29.49% Gain from 52W Low

Volume: 238.6K

Ipca Laboratories Ltd.

30 Sep 2024

1362.20

0.03%

Bayshore integration to unlock growth

Buy: Ipca Laboratories Ltd.

Target

Sharekhan

Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.

Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.